FDA issues warning to Curaleaf for 'illegally selling' CBD products with 'unsubstantiated claims'
July 23, 2019 at 11:05 AM EDT
The Food and Drug Administration issued a warning letter to Curaleaf for allegedly "illegally selling" CBD products with "unsubstantiated claims" like the products treating cancer, Alzheimer's disease, opioid withdrawal, pain and pet anxiety.
